Cargando…
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
Ovarian cancer is the most lethal gynecologic malignancy. Surgery and chemotherapy are the primary treatments for ovarian cancer; however, patients often succumb to recurrence with chemotherapeutic resistance within several years after the initial treatment. In the past two decades, immunotherapy ha...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572849/ https://www.ncbi.nlm.nih.gov/pubmed/33123161 http://dx.doi.org/10.3389/fimmu.2020.577869 |